Issuer Free Writing Prospectus
Filed pursuant to Rule 433
Registration No. 333-268907
January 23, 2023
QuantaSing Group Limited
![LOGO](https://capedge.com/proxy/FWP/0001193125-23-012977/g715255g0117221600576.jpg)
QuantaSing Group Limited, or our company, has filed a registration statement on Form F-1, including a prospectus, with the Securities and Exchange Commission, or the SEC, for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that registration statement and other documents our company has filed with the SEC for more complete information about our company and this offering. Investors should rely upon the prospectus and any relevant free writing prospectus for complete details. You may obtain these documents and other documents our company has filed for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, we or any underwriter or any dealer participating in the offering will arrange to send you the prospectus, if you request it, through the following contacts: Citigroup Global Markets Inc., at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, United States of America, by calling 1-800-831-9146 or via email: prospectus@citi.com; China International Capital Corporation Hong Kong Securities Limited, at 28th Floor, 350 Park Avenue, New York, NY 10022, United States of America, by calling 1-646-794-8800 or via email: g_prospectus@cicc.com.cn; US Tiger Securities, Inc., at 437 Madison Ave, 27th Floor, New York, NY 10022, United States of America, by calling 1-646-978-5241 or via email: tony.tian@ustigersecurities.com; CLSA Limited, at 18/F, One Pacific Place, 88 Queensway, Hong Kong; and/or Univest Securities, LLC, at 75 Rockefeller Plaza, Suite 1838, New York, NY 10019, United States of America, by calling 1-212-343-8888 or via email: info@univest.us. You may also access our company’s most recent preliminary prospectus dated January 13, 2023 which is included in Amendment No. 1 to our company’s registration statement on Form F-1, as filed on January 13, 2023, or Amendment No. 1, by visiting EDGAR on the SEC website at https://www.sec.gov/Archives/edgar/data/1932770/000119312523008410/d715255df1a.htm
The following information supplements and updates the information contained in our company’s preliminary prospectus included in Amendment No. 1, or the preliminary prospectus. This free writing prospectus reflects the following amendments that were made to the preliminary prospectus. All references to page numbers are to page numbers in the preliminary prospectus.
1. Amend the status of the Nasdaq’s listing approval for this offering by (i) amending the second sentence of the second paragraph on the cover page, the first sentence of the third column titled “Listing” in the table on page 20, the first sentence of the risk factor titled “An active trading market for our ordinary shares or the ADSs may not develop and the trading price for the ADSs may fluctuate significantly” on page 75, the second sentence of the second paragraph on page 213, and the fourth paragraph on page 224 as follows.
We have been approved to list the ADSs on the Nasdaq Global Market, under the symbol “QSG.”
(ii) amending the second sentence of the second paragraph under “Dividends” on page 219 as follows.
After we list the ADSs on the Nasdaq Global Market, we believe that the ADSs will be readily tradable on an established securities market in the United States and that we will be a qualified foreign corporation with respect to dividends paid on the ADSs.
2. Add the following as the second sentence of the ninth paragraph on the cover page, the second sentence of the first paragraph under the section titled “The Holding Foreign Companies Accountable Act” on page 14, and the second sentence of the last risk factor titled “The ADSs will be delisted and our shares and ADSs will be prohibited from trading in the over-the-counter market under the Holding Foreign Companies Accountable Act, if the PCAOB is unable to inspect or investigate completely auditors located in China for two consecutive years. The delisting of the ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment” on page 63.
Our auditor, PricewaterhouseCoopers Zhong Tian LLP, is an independent registered accounting firm based in mainland China.